The full submission pathway, pre-screening, dossier intake, classification, technical committee review, pricing, certificate issuance, with the timeline ranges we observe in practice.
Risk classes, IFU language, technical file depth, and where most foreign manufacturers misjudge their device's risk category.
ReadThe transition from MOHAP-only pathways to EDE-centralised review, what changes, what doesn't, and what to file where.
ReadProvider eligibility, controlled medicine prescribing, and the operational changes telehealth operators need to make by Q4.
ReadA practitioner's walkthrough of NABIDH onboarding via certified EMR vendors, vendor selection, data flow, and conformance testing.
ReadPV Master File requirements, QPPV qualifications, and the reporting cadence MOHAP expects from registered MAHs.
ReadWhat the UAE Pharmacopoeia covers, where it diverges from USP/EP/BP, and how to align your CTD module 3 accordingly.
ReadWhat an AR actually does in the UAE, the post-market obligations attached, and the contractual structures we use with foreign OEMs.
ReadTemperature mapping, validated lanes, and the documentation regulators expect when your product enters at 2 to 8°C or below.
ReadReference pricing, external benchmarking, and the negotiation cadence we observe in the MOHAP pricing committee.
Read